Darapladib
Darapladib is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.25 nM. Phase 3.
| Trivial name | SB-480848 |
| Catalog Number | S7520 |
| Molecular Formula | C36H38F4N4O2S |
| CAS# | 356057-34-6 |
| Inchi | InChI=1S/C36H38F4N4O2S/c1-3-42(4-2)20-21-43(22-25-8-12-27(13-9-25)28-14-16-29(17-15-28)36(38,39)40)33(45)23-44-32-7-5-6-31(32)34(46)41-35(44)47-24-26-10-18-30(37)19-11-26/h8-19H,3-7,20-24H2,1-2H3 |
| Inchi Key | WDPFJWLDPVQCAJ-UHFFFAOYSA-N |
| SMILES | CCN(CC)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCC5=CC=C(C=C5)F |
| Size | 25mg |
| Supplier Page | http://www.selleckchem.com/products/darapladib-sb-480848.html |
| Additional Information | https://file.selleck.cn/downloads/struct/Darapladib-chemical-structure-s7520.gif |